The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin β in peritoneal dialysis patients with chronic renal anaemia-Reference-Cited by-同舟云学术

The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin β in peritoneal dialysis patients with chronic renal anaemia

Published:2005-03-15 Issue:5 Volume:20 Page:936-944
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Grzeszczak Wladyslaw,Sulowicz Wladyslaw,Rutkowski Boleslaw,de Vecchi Amedeo F.,Scanziani Renzo,Durand Pierre-Yves,Bajo Auxiliadora,Vargemezis Vassilis

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/20/5/936/5239857/gfh761.pdf

Reference25 articles.

1. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J1990; 300: 573–578

2. Mocks J. Cardiovascular mortality in haemodialysis patients treated with epoetin beta – a retrospective study. Nephron2000; 86: 455–462

3. Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant2003; 18: 353–361

4. Bajo MA, Selgas R, Castro MJ et al. Erythropoietin treatment decreases cardiovascular morbidity and mortality in CAPD patients. Perit Dial Int1997; 17: 129–135

5. European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant1999; 14 [Suppl 5]: 1–50

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?;Cureus;2020-09-10

2. Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients;Saudi Pharmaceutical Journal;2015-10

3. Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2015-07

4. Investigation of the Efficacy of a Biogeneric Recombinant Human Erythropoietin Alfa in the Correction of Post-Transplantation Anemia: A Randomized Comparative Trial with Eprex;Clinical Laboratory;2013

5. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin;Blood;2009-06-25